Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.
作者
Farshad Nassiri,Michael D. Cusimano,Bernd Walter Scheithauer,Fabio Rotondo,Alessandra Fazio,George M. Yousef,Luis V. Syro,Kálmán Kovács,Ricardo V. Lloyd
出处
期刊:PubMed [National Institutes of Health] 日期:2011-06-01卷期号:31 (6): 2283-90被引量:297
Endoglin (CD105) is an accessory receptor for transforming growth factor beta (TGF-β) and its expression is up-regulated in actively proliferating endothelial cells. Endoglin has been suggested as an appropriate marker for tumor-related angiogenesis and neovascularization. Several studies demonstrate the potential of endoglin in tumor diagnosis, prognosis, and therapy. This review details the structure and function of endoglin, and investigates the role of endoglin in angiogenesis and tumor diagnosis, prognosis, and therapy.